Nagi Bioscience is a life-science-tech company developing a revolutionary technology for the in vitro testing of drugs and chemicals. Its technology aims to revolutionize the way toxic and beneficial effects of substances are tested. The company uses microfluidics and microscopic worms to provide a new sustainable alternative to traditional animal testing to pharma, chemical, cosmetic industries, and biomedical research.
|Employees (est.) (Apr 2021)||6|
Nagi Bioscience total Funding
Nagi Bioscience latest funding size
Time since last funding
|a year ago|
Nagi Bioscience investors
|investiere, Zürcher Kantonal Bank, Verve Capital Partners, NEST pension fund|
Nagi Bioscience has 197 Twitter Followers. The number of followers has increased 0.6% month over month and increased 4.8% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Nagi Bioscience founded?
Nagi Bioscience was founded in 2019.
Who are Nagi Bioscience key executives?
Nagi Bioscience's key executives are Matteo Cornaglia, Laurent Mouchiroud and Fabien Tâche.
How many employees does Nagi Bioscience have?
Nagi Bioscience has 6 employees.
Who are Nagi Bioscience competitors?
Competitors of Nagi Bioscience include ProteinSimple, Microbiologics and BioLegend.
Where is Nagi Bioscience headquarters?
Nagi Bioscience headquarters is located at Route Cantonale, Lausanne.
Where are Nagi Bioscience offices?
Nagi Bioscience has an office in Lausanne.
How many offices does Nagi Bioscience have?
Nagi Bioscience has 1 office.
Receive alerts for 300+ data fields across thousands of companies